Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Bardoxolone methyl receives orphan drug designation in Europe for the treatment of Alport syndrome

June 4, 2018

Kyowa Hakko Kirin initiated phase III trial of bardoxolone methyl for diabetic kidney disease

June 4, 2018

Phase II study of MGL-3196 in NASH achieves liver biopsy endpoints at 36 weeks

June 1, 2018

Researchers from U.S. patent 5-HT1F receptor agonists

May 31, 2018

Atox initiates phase II trial of reltecimod in acute kidney injury

May 30, 2018

CLCF1 biomarker may help diagnose delayed graft function in kidney transplantation

May 25, 2018

Novo Nordisk licenses EPGN-696 from Epigen

May 25, 2018

VFMCRP and Cara sign development and commercialization agreement for CR-845

May 23, 2018

FDA approves Lokelma for hyperkalemia

May 22, 2018

Bayer patents new vasopressin V1A and V2 receptor antagonists

May 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...